Menopause HRT Protocol Planner
Combine vasomotor symptom intensity, estradiol deficiency, age, and progesterone balance to estimate a starting transdermal estradiol patch dose. Use the suggested mg/day value as a conversation starter with your menopause specialist and adjust based on follow-up labs and risk factors.
Educational only; hormone therapy must be prescribed and monitored by a healthcare professional.
Examples
- 52-year-old with severe vasomotor symptoms (score 9), estradiol 25 pg/mL, progesterone 6 ng/mL ⇒ 0.056 mg/day starting dose
- 48-year-old endurance athlete, symptom score 5, estradiol 35 pg/mL, progesterone 12 ng/mL ⇒ 0.036 mg/day patch recommendation
FAQ
Does this calculator replace medical advice?
No. It provides a data-informed starting point for a conversation with your clinician. Always confirm labs, contraindications, and follow-up frequency with a licensed provider.
How often should I retest hormones?
Most protocols repeat estradiol and progesterone every 8–12 weeks during titration, then every 6–12 months once stable.
What if I use oral or gel formulations?
Convert the suggested mg/day patch dose to the equivalent oral or gel dose using your clinic’s conversion chart. The severity weighting still guides how aggressively to initiate therapy.
Additional Information
- Dose suggestions cap at 0.100 mg/day to reflect common upper bounds for transdermal estradiol patches.
- Values below 0.015 mg/day are rounded up to remain practical relative to commercially available patch strengths.
- Symptom scores above 8 weight dose escalation more aggressively to prioritise relief before gradual tapering.
- Progesterone inputs modulate the recommendation—lower progesterone bumps estradiol upward to support balance.